Summary Factors influencing time to loco-regional recurrence were identified in a multivariate regression analysis of data from a series of 468 radically operated patients (260 Dukes' B and 208 Dukes' C) with carcinoma of the rectum and the rectosigmoid. A number of clinical and pathological characteristics were prospectively collected and recorded. In addition, carcinoembryonic antigen (CEA) was measured within I week before surgery. The endpoint used was recurrence below the level of the umbilicus. All patients were followed for at least 5 years or until time of death.
Loco-regional control remains a major problem among patients with Dukes' B or C colorectal carcinoma even in cases where surgery is judged to be radical. Several randomised (Balslev et al., 1982; Gastrointestinal Tumor Study Group, 1985; Fisher et al., 1988) or historically-controlled clinical trials (Tepper et al., 1987; Vigliotti et al., 1987; Mohiuddin et al., 1985) have been concerned with the possible benefit from adjuvant post-operative radiotherapy in this disease. With respect to survival all have come out negative (Bentzen et al., 1988a; Douglass et al., 1986; Fisher et al., 1988) : postoperative radiotherapy has not improved survival significantly even when quite substantial numbers of patients are compared. With respect to loco-regional control or disease-free survival diverse conclusions have been reached: in the NSABP study R-01 there was an overall reduction in loco-regional recurrence from 25% to 16% (P = 0.06 (Fisher et al., 1988) ), while the GITSG study found no significant reduction in the loco-regional recurrence rate after adjuvant radiotherapy (Gastrointestinal Tumour Study Group, 1985) . One possible explanation is that the very large variability in natural history of colorectal carcinoma (Bentzen et al., 1988a) , even within a specific Dukes' stage, might over- shadow the possible benefit from adjuvant therapy (Tannock, 1989; Bentzen et al., 1988a) . The present multivariate analysis of clinico-pathological factors affecting the time to locoregional recurrence was undertaken in order to define highrisk subpopulations of patients with Dukes' B and C tumours. Furthermore, we discuss the potential gain from restricting trials of therapies aimed at improving the locoregional control to these high risk patients. 
Methods and materials
A total of 494 patients were randomised in a multicenter study (Balslev et al., 1982; Balslev et al., 1986; Bentzen et al., 1988a) of the effect of postoperative adjuvant radiotherapy after resection of Dukes' B and C colorectal cancer. The study was open for patient intake from September 1979 to March 1984 (Dukes' B) or March 1985 (Dukes' C) . Staging was performed according to Dukes' classification (Dukes & Bussey, 1958) , with B tumours defined as having penetrated the bowel wall completely, and C tumours as having regional lymph node metastases regardless of the degree of bowel-wall penetration. Exclusion criteria were: tumour above the pelvis, patients aged over 80 years, surgery judged to be non-radical, patients bedridden more than 50% of the day 20-25 days after surgery, post-operative complications, previous cancer within 5 years, and previous radiotherapy. Details of the study design and the results of the randomised trial have previously been published (Balslev et al., 1982; Balslev et al., 1986; Bentzen et al., 1988a; Kronborg et al., 1988) .
Clinical, pathological and biochemical data, evaluated and recorded prospectively, formed the basis for two separate multivariate analyses (Bentzen et al., 1988a ) of prognostic factors in 260 patients with Dukes' B and 208 patients with Dukes' C carcinoma of the rectum and the rectosigmoid who had complete data records. Here, a similar analysis is presented using locoregional recurrence as the endpoint.
Postoperative radiotherapy As a general rule, radiotherapy was started within 30 days after surgery, but in patients with surgical complications this period could be up till 60 days. The total target dose was 50 Gy given in 2 Gy per fraction, five fractions per week. A split-course schedule was employed with a 2 week break after 30 Gy. All patients were treated in the prone position with 8-16 MV photons using one posterior and two parallel opposing lateral fields or with a four-field technique using two parallel opposing lateral fields and two parallel opposing anterior-posterior fields. All fields were treated in each treatment session.
The target volume included the entire pelvis with the proximal field limit at the mid-level of the 5th lumbar vertebra. In patients having anterior or low anterior resection the distal field limit was the lower margin of the obturator foramen, whereas in patients having abdominoperineal resection the field included the perineal region. Laterally, the pelvic brim was included with a 1.5 to 2cm margin. The lateral fields included the posterior surface of the symphysis and the entire sacral cavity with proximal/distal field limits matching those of the posterior field. The target volume was defined on ordinary simulator radiographs and individually shaped shielding blocks were made to encompass the target volume with a 2 to 3 cm margin.
A detailed account of treatment-related complications have been presented by Balslev et al. (1986) . transient prolongation of the time to loco-regional recurrence in Dukes' C patients treated with adjuvant radiotherapy (Figure 1) . However, at about 2.5 years the two loco-regional control curves cross. If all observations were censored at 1.5 years there appeared to be a highly significant advantage from adjuvant radiotherapy, the P-value being less than 0.006 with both the Mantel-Cox and the Gehan-Breslow tests. When censoring was done at 2 years the advantage was borderline significant when using the Mantel-Cox test statistics (v? = 3.01, P = 0.08) but still significant at the 5% level when applying the Gehan-Breslow test (X2 = 4.84, P = 0.03).
At 5 years none of the two tests revealed a significant benefit from radiotherapy.
The multivariate PHM analyses were restricted to those patients having complete data records. Table II (Kaplan & Meier, 1958) . When comparing two groups only, the Mantel-Cox log rank test (Mantel, 1966) or the Gehan-Breslow tests (Gehan, 1965) (Tarone, 1975) based on the logrank test was used.
Multivariate regression analysis of time to loco-regional recurrence in the two Dukes' stages was conducted using the Cox' Proportional Hazards Model (PHM) (Cox, 1972) . Quantitation of the observed differences in loco-regional control rates was obtained by the ratio of hazard rates estimated from the Cox PHM or, in the univariate case, by the MantelHaentzel estimate (Crowley, 1975) . The endpoint used in the analyses was any recurrence below the level of the umbilicus. All patients were followed for 5 years or until time of death.
Results
An update of the 5-year treatment results among all randomized patients is presented in Table I . In both Dukes' B and C patients no statistically significant benefit from adjuvant radiotherapy, as administered in the CRES study, could be demonstrated with respect to either 5-year crude survival or loco-regional control. In the Dukes' B group, the hazard rate for loco-regional recurrence among patients treated with surgery alone was estimated to be 1.14 (95% c.l. 0.64-2.0) times as high as that of patients who received postoperative radiotherapy. In the Dukes' C group the ratio of hazard rates was 1.01 (95% c.l. 0.64-1.6). Thus the relative risk of loco-regional recurrence was not significantly different from one when comparing patients who did or did not receive post-operative radiotherapy. There seemed, however, to be a Obs. time (years) Figure 1 Loco-regional control vs observation time after resection for Dukes' B or C tumours with or without adjuvant radiotherapy. Number of patients and estimated 5-year control probabilities in the various groups are found in Table I . (Table III) . There was no trend towards a gradual worsening of the prognosis with increasing age below 70 years. The same picture was seen in the multivariate analysis where age above 70 was also statistically significant (Table  IV) . Using the number of years above 70 as a covariate in the PHM analysis resulted in a poorer fit than simply grouping the patients in those below and above 70 years of age. In patients with Dukes' C tumours age had no significant influence in predicting loco-regional outcome.
Localisation
The distance from the anal verge had a significant influence on the time to loco-regional recurrence in both stages Dukes' B and C where patients with higher situated tumours did better than those with a less than 10 cm distance from the anal verge (Table IV) .
Tumour size Univariate analyses showed a statistically significant improvement in loco-regional control with increasing tumour size in Dukes' B tumours whereas no significant trend was observed in the Dukes' C group (Table V) . In the multivariate analyses (Table IV) , the trend in Dukes' B patients was still seen (P = 0.04) but in Dukes' C tumours maximum tumour diameter turned out to be highly significant (P = 0.0004) when allowing for other patient characteristics.
Note that the negative regression coefficient (p) in Table IV means that the hazard of loco-regional recurrence is decreasing with increasing tumour size. (Table II) . However, this was the strongest single determinant of loco-regional control in patients with Dukes' C tumours (Table IV) . No significant effect of this covariate could be demonstrated in Dukes' B cases.
Microscopic appearance Perineural invasion had a highly significant and strongly negative influence on loco-regional control probability in both Dukes' stages (Table IV) (Figure 2 ) showed no significant importance of this parameter in either of the two Dukes' stages with respect to prediction of locoregional outcome. The cutpoints used for pooling -the patients were the median and the 75 percentile of the CEA distribution of all Dukes' B and C patients taken together.
Prognostic forecasts
The PHM allows prognostic forecasts to be made in groups or individual patients as discussed in some detail previously (Bentzen et al., 1988b; Bentzen et al., 1988a; Bentzen et al., 1990) . Figure 3 shows the predicted loco-regional control vs observation time in four hypothetical patients (Table VI) . These patients were selected to have characteristics associated Table VI . (Bentzen et al., 1988a) , an effect of adjuvant postoperative radiotherapy was specifically sought for in the group of high-risk patients. All patients with Dukes' C tumours were grouped into four categories according to the quartiles of the distribution of relative hazard rates estimated from the PHM analysis. In each of these four groups, the loco-regional control was compared between patients randomised to surgery alone as opposed to patients who were randomised to receive adjuvant radiotherapy. Only in the high-risk group, that is among the quarter of the patients with the highest probability of developing a loco-regional recurrence, was a significant difference seen in favour of patients receiving radiotherapy ( (Bentzen et al., 1988a) . The same pattern was not seen with respect to loco-regional control, when the control probability appeared to be independent of age up to 70 years and with a poorer prognosis beyond that age (Table  III) . This is in agreement with multivariate survival analyses (Bentzen et al., 1988a; Chapuis et al., 1985) but contrasts the findings in a number of univariate analyses (Rich et al., 1983; Block & Enker, 1971; Jensen et al., 1970) . Probably, the observed association between low malignancy grade and age (Dukes & Bussey, 1958) , corrected for in multivariate analyses, may have confounded the univariate analyses.
Localisation
A number of investigators (Bentzen et al., 1988a; Sugarbaker et al., 1985) have noted that low situated tumours do worse than those located at larger distances from the anal verge. Probably, this is a consequence of both the difficulty in obtaining a tumour-free lateral resection margin in the low situated tumours (Quirke et al., 1986 ) and of the difference in lymphatic drainage between these tumours and the higher situated ones (Sugarbaker et al., 1985) .
Tumour size
The prognostic significance of the size of the primary tumour seems to be different in the two Dukes' stages analysed here (Table IV) (Table II) . Despite the relatively low frequency of this characteristics, it was found to be associated with a statistically significantly higher risk of developing a locoregional recurrence in patients with Dukes' C tumours. Moreover, this was the strongest single risk factor with an estimated hazard in a patient where resection of other organs was necessary of 2.4 times as high as in a patient where this was not the case, all other characteristics being equal. In patients with Dukes' B tumours, resection of other organs did not reach statistical significance in the PHM analysis, neither when using loco-regional control as the endpoint nor when looking at survival (Bentzen et al., 1988a) .
Microscopic appearance Already Seefeld and Bargen (1943) observed an increased rate of local recurrences in patients with perineural invasion. Here, this was the single most important parameter in predicting loco-regional outcome in patients with Dukes' B tumours and the second most important in patients with Dukes' C tumours. In our previous analysis of survival data (Bentzen et al., 1988a) , perineural invasion was the strongest prognosticator in both Dukes' stages. Venous invasion was associated with an increased risk of loco-regional recurrence in patients with Dukes' C tumours (Table IV) . In patients with Dukes' B tumours, venous invasion, of borderline significance (P = 0.07) when using survival as the endpoint, was not a significant factor in predicting loco-regional outcome.
Histopathologic grading has no independent influence of the time to loco-regional recurrence when other clinicopathological characteristics are allowed for in a multivariate analysis.
Sex and preoperative CEA Elevated preoperative CEA was found by Wanebo et al. (1978) to be significantly associated with disease-free survival. Analysing the present series, using death with cancer as the endpoint (Bentzen et al., 1988a) , demonstrated the same association in a multivariate analysis. However, the risk of loco-regional recurrence was unaffected by the level of preoperative CEA. One possible explanation is that elevated preoperative CEA could be associated with a higher risk of occult distant metastasis. Direct testing of this hypothesis awaits an anlaysis of data on distant relapses in the present study.
The prognostic importance of sex has yet to be estimated. One multivariate analysis (Chapuis et al., 1985) found a significantly better survival rate in females than in males and the authors proposed an influence of pregnancy and parity. This result was not confirmed by Bentzen et al. (1988a) although sex had a P-value of 0.07 in the Dukes' C group when survival was used as the endpoint. However, in the present analysis there was no significant association between, sex and loco-regional outcome in either of the Dukes' stages.
Adjuvant post-operative radiotherapy
Censoring all observations at 1.5 or 2 years showed a significant benefit with respect to loco-regional control after adjuvant radiotherapy. However, when 5 years of follow-up was available the temporary advantage of adjuvant radiotherapy cancelled out (Table I) . Therefore it is appropriate to warn against premature analysis and reporting of loco-regional control in patients with Dukes' C tumours. An early analysis of the Danish Colorectal Cancer trial (Balslev et al., 1986) found a statistically significantly reduced risk of local recurrence at 2 years; a reduction that was found to be insignificant when extending the observation time to 45 months (I, = 2.67, P = 0.1). However, at that time only 12 and nine patients were at risk at 45 months in the radiotherapy and surgery-alone arms, respectively.
When looking at the results among the high-risk patients, a significant reduction in loco-regional recurrence rate was seen after postoperative radiotherapy. This was not a datagenerated hypothesis, but rather based on the a priori expectation that radiotherapy would yield maximum benefit with respect to loco-regional control in this specific group of patients. The improved loco-regional control did not cause any significant improvement in survival. It should be noted, though, that the test-strength for detecting a clinically relevant improvement in survival is low because of the limited number of patients. Distant metastases constitute a serious therapeutic problem in the same high-risk patients and the potential gain from improved loco-regional control with respect to survival is difficult to assess.
In the group with Dukes' B tumours there was no significant benefit from radiotherapy in any of the risk-defined subsets.
Other strategies for combined surgery and radiotherapy have been suggested: preoperative radiotherapy or combined pre-and postoperative (so-called sandwich) radiotherapy. Although several trials, historically controlled or randomised (see the review by Cohen et al., 1989 and Dahl et al., 1990) , have found an improved local control after combined surgery and radiotherapy the actual importance, if any, of the sequence of the two treatment modalities remains to be investigated. Furthermore, in most of these trials the improvement in local control after preoperative radiotherpy did not result in any significant improvement in survival (Mayer et al., 1989; Cohen et al., 1989) .
Designing trials of intensified local treatment The large variability in the natural history of colorectal cancer, even within each Dukes' category, has some potentially important implications for the design of randomised trials of more effective loco-regional treatment in this disease. About 15% of those patients with Dukes' C tumours, who fulfilled the inclusion criteria for the CRES trial, has a predicted 5-year loco-regional control rate of 30% or less (Figure 4 Obs. time (years) Figure 4 About 15% of the patients with Dukes' C tumours have an estimated 5-year loco-regional control rate of less than 30%. These patients have a predicted loco-regional control curve falling within the hatched area. A hypothetical therapy controlling 50% of the loco-regional recurrences seen after surgery alone would improve the overall 5-year loco-regional control from 19% to 59% (indicated by the arrow).
*This subgroup of patients with Dukes' C tumours is not readily characterised by their clinico-pathological features. Technically, they may be found as patients in whom the sum (over all relevant characteristics) of the products of the PHM score (Table II) times the regression coefficient (, in Table IV) is equal to or greater than 1.88. An example is the 'poor case' of Table VI. C Dukes' C patients with an estimated 5-year control rate in the group as a whole of only 19%. Obviously, these patients would be candidates for a more effective adjuvant regional treatment. At the other end of the scale there are groups of Dukes' C patients with a very high probability of obtaining loco-regional control. Inclusion of these low-risk patients in a clinical trial would tend to dilute the possible benefit from a more efficient experimental treatment. To illustrate this point, assume that a novel therapy, say, a more intense radiotherapy regimen, is being tested. The treatment is expected to control half of the loco-regional recurrences seen with the current therapies, that is the 5-year loco-regional control rate among patients with resectable Dukes' C tumours would increase from 67% to 83%. Even this relatively effective hypothetical treatment would require quite a large number of patients to be entered in a randomised trial. Assuming that the proposed trial is open for patient intake in 3 years and that an additional follow-up period of 3 years is added, then with a two-sided confidence level of 0.05 and a power of the test of 90%, an accrual rate of 70 patients per year is required. Now, assume that the relative efficacy of the novel therapy is the same among the high-risk patients defined above, i.e. that half of the potential recurrences are controlled by the new treatment regimen. Then, if the trial is restricted to these patients, the control rate would increase from 19% to 60% (Figure 4) . A calculation shows that this would reduce the accrual rate to only 23 patients per year, that is a little less than one third of the number of patients needed when applying the treatment to all Dukes' C patients.
Conclusion
Subgroups of patients with Dukes' B or C colorectal cancer have been identified with a probability of loco-regional control that differs markedly from the average within the two stages. Such variability may overshadow the potential benefit of more aggressive loco-regional treatments. However, the present study suggests that patients with Dukes' C tumours and with a high risk of loco-regional recurrence may benefit from postoperative radiotherapy. If this hypothesis is tested in the group of patients assumed to have maximal benefit from loco-regional treatment, a considerable decrease will result in the number of patients needed as compared to a trial testing radiotherapy among all Dukes' C patients.
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